<p>Timing of treatment intensification after risk factor test (number of patients per 10 days period).</p
Mean (SD) interval in days between last exposure and testing–first RDT study (asymptomatic close con...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Timing of response to treatment evaluation after treatment intensification (number of patients pe...
<p>Percentage of all patients diagnosed by visit 2 (assumed 5 days after first visit), by visit 3 (a...
<p>The relationship between the timing of treatment post-diagnosis and the cost-effectiveness of a s...
<p>Average number of possibly and probably related (both solicited and unsolicited) AE per previousl...
Time to first treatment (62-day target) by treatment category for cancer patients who survived 90 da...
Factors affecting late initiation of appropriate treatment (≥ 60 days from the first institution vis...
<p>Time intervals from day of clinical MM diagnosis (= 0) to start of chemotherapy, kidney biopsy an...
<p>Frequency of initiation of medication therapy before and after intervention (*p<0.05).</p
Proportions of patients receiving treatments within 30-day of the discharge date of the index inpati...
Observation period and defined risk periods for an individual person receiving oral glucocorticoid t...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
Mean (SD) interval in days between last exposure and testing–first RDT study (asymptomatic close con...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Timing of response to treatment evaluation after treatment intensification (number of patients pe...
<p>Percentage of all patients diagnosed by visit 2 (assumed 5 days after first visit), by visit 3 (a...
<p>The relationship between the timing of treatment post-diagnosis and the cost-effectiveness of a s...
<p>Average number of possibly and probably related (both solicited and unsolicited) AE per previousl...
Time to first treatment (62-day target) by treatment category for cancer patients who survived 90 da...
Factors affecting late initiation of appropriate treatment (≥ 60 days from the first institution vis...
<p>Time intervals from day of clinical MM diagnosis (= 0) to start of chemotherapy, kidney biopsy an...
<p>Frequency of initiation of medication therapy before and after intervention (*p<0.05).</p
Proportions of patients receiving treatments within 30-day of the discharge date of the index inpati...
Observation period and defined risk periods for an individual person receiving oral glucocorticoid t...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
Mean (SD) interval in days between last exposure and testing–first RDT study (asymptomatic close con...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
DOI
Add to ORKG